Prenetics Global (Prenetics Global) Interest Expense : USD-0.14 Mil (TTM As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Prenetics Global Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Prenetics Global's interest expense for the three months ended in Sep. 2023 was USD -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was USD-0.14 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Prenetics Global's Operating Income for the three months ended in Sep. 2023 was USD -14.77 Mil. Prenetics Global's Interest Expense for the three months ended in Sep. 2023 was USD -0.04 Mil. Prenetics Global did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Prenetics Global Interest Expense Historical Data

The historical data trend for Prenetics Global's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prenetics Global Interest Expense Chart

Prenetics Global Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.07

-0.06

-0.23

-0.45

-0.12

Prenetics Global Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial									3.55	-0.08	-0.05	-0.04	0.03

Prenetics Global Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was USD-0.14 Mil.

Prenetics Global (NAS:PRE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Prenetics Global's Interest Expense for the three months ended in Sep. 2023 was USD-0.04 Mil. Its Operating Income for the three months ended in Sep. 2023 was USD-14.77 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was USD3.06 Mil.

Prenetics Global's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Prenetics Global did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Prenetics Global (Prenetics Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG

Website

https://www.prenetics.com

Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.